- Home
- RCKT vs PAXS Comparison
RCKT vs PAXS Comparison
Compare RCKT & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- PAXS
- Stock Information
- Founded
- RCKT 1999
- PAXS 2021
- Country
- RCKT United States
- PAXS United States
- Employees
- RCKT N/A
- PAXS N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- PAXS Investment Managers
- Sector
- RCKT Health Care
- PAXS Finance
- Exchange
- RCKT Nasdaq
- PAXS Nasdaq
- Market Cap
- RCKT 764.5M
- PAXS 717.7M
- IPO Year
- RCKT N/A
- PAXS N/A
- Fundamental
- Price
- RCKT $2.77
- PAXS $15.09
- Analyst Decision
- RCKT Buy
- PAXS
- Analyst Count
- RCKT 11
- PAXS 0
- Target Price
- RCKT $21.77
- PAXS N/A
- AVG Volume (30 Days)
- RCKT 7.4M
- PAXS 195.0K
- Earning Date
- RCKT 05-08-2025
- PAXS 01-01-0001
- Dividend Yield
- RCKT N/A
- PAXS 11.72%
- EPS Growth
- RCKT N/A
- PAXS N/A
- EPS
- RCKT N/A
- PAXS N/A
- Revenue
- RCKT N/A
- PAXS N/A
- Revenue This Year
- RCKT N/A
- PAXS N/A
- Revenue Next Year
- RCKT N/A
- PAXS N/A
- P/E Ratio
- RCKT N/A
- PAXS N/A
- Revenue Growth
- RCKT N/A
- PAXS N/A
- 52 Week Low
- RCKT $2.19
- PAXS $12.57
- 52 Week High
- RCKT $26.98
- PAXS $15.93
- Technical
- Relative Strength Index (RSI)
- RCKT 27.94
- PAXS 49.87
- Support Level
- RCKT $2.19
- PAXS $14.58
- Resistance Level
- RCKT $2.67
- PAXS $15.32
- Average True Range (ATR)
- RCKT 0.54
- PAXS 0.19
- MACD
- RCKT -0.45
- PAXS 0.01
- Stochastic Oscillator
- RCKT 11.72
- PAXS 68.92
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.